C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
12/2006
12/07/2006	US20060276380 Gomesin has 18 amino acid residues, configured as a hairpin structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cysteine forming two disulfide bridges, configurable as a cyclic chain with open or closed ends; low hemolytic activity
12/07/2006	US20060275826 Artificial antibody comprising complementary peptide
12/07/2006	US20060275791 Biological control of nanoparticle nucleation, shape and crystal phase
12/07/2006	US20060275775 Intramolecularly-quenched near infrared fluorescent probes
12/07/2006	US20060275213 Tumor targeting agents and uses thereof
12/07/2006	CA2610496A1 Synthetic peptide inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
12/07/2006	CA2609951A1 Backbone cyclized melanocortin stimulating hormone (.alpha.s) analogs
12/07/2006	CA2607471A1 Binding partners of the placental growth factor, especially antibodies directed against the placental growth factor, production and use thereof
12/06/2006	EP1728515A1 Influenza virus-infection inhibitor
12/06/2006	EP1727904A1 Peptide-based method for monitoring gene expression in a host cell
12/06/2006	EP1682571A4 A bidentate motif and methods of use
12/06/2006	EP1682570A4 A binding motif and methods of regulating cell function
12/06/2006	EP1477181B1 Method of stimulating growth and resistance to diseases of aquatic organisms
12/06/2006	EP0983346B1 Short peptides which selectively modulate the activity of serine/threonine kinases
12/06/2006	EP0938503B1 Insulin c-peptides
12/06/2006	EP0820598B1 Assaying protein fragments in body fluids
12/06/2006	EP0740701B1 Mammalian monocyte chemoattractant protein receptors
12/06/2006	CN1875032A Biological active peptides comprising isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonine
12/06/2006	CN1872873A Function of cytoinhibition peptide for treating rheumatoid arthritis
12/06/2006	CN1288165C A preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium
12/05/2006	US7144982 Polypeptides with therapeutic activity and methods of use
12/05/2006	US7144864 Carboxypeptidase R inhibiting peptide
12/05/2006	US7144862 Orally administered peptides to ameliorate atherosclerosis
12/05/2006	US7144860 Amd to ischemic tissue; treating atherosclerosis and restenosis.
12/05/2006	US7144859 Somatostatin agonists
12/05/2006	US7144858 Antibacterial compounds and methods for treating Gram positive bacterial infections
12/05/2006	US7144697 Synthetic antigen for the detection of antibodies immunoreactive with HIV virus
12/05/2006	US7144569 Mutant gliadin protein whose wild-type sequence can be modified by transglutaminase; fusion protein comprising a non-gliadin sequence; kit comprising antibody to interferon- gamma detects recognition by T-cell
11/2006
11/30/2006	WO2006128027A1 Functionally active recombinant peptides, methods for producing same and interactions with other peptides
11/30/2006	WO2006126263A1 Vhl peptide
11/30/2006	WO2006095128A3 Rodent pest control
11/30/2006	WO2006086012A8 Antibiotic compound
11/30/2006	WO2006029383A3 Combinatorial artificial receptors including peptide building blocks
11/30/2006	US20060270832 Novel x-conotoxin peptides (-II)
11/30/2006	US20060270829 G-csf conjugates
11/30/2006	US20060270606 Dolastatin 15 derivatives
11/30/2006	US20060270605 Compositions and methods for inhibiting cell growth and modulating gene expression
11/30/2006	US20060269988 Complete biosynthetic gene set for synthesis of polyketide antibiotics, including the albicidin family, resistance genes, and uses thereof
11/30/2006	US20060269960 Isolated peptides corresponding to amino acid requirements of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof
11/30/2006	US20060269477 ST receptor binding compounds and methods of using the same
11/29/2006	EP1725659A2 Natural igm antibodies and inhibitors thereof
11/29/2006	EP1725580A2 Isosteric transformation
11/29/2006	EP1725579A1 Peptides derived from human bplp protein, polynucleotides coding for said peptides and antibodies directed against said peptides
11/29/2006	EP1725578A1 A novel potassium channel modulator peptide
11/29/2006	EP1725249A2 Monomethylvaline compounds capable of conjugation to ligands
11/29/2006	EP1581645A4 Method for using division arrested cells in screening assays
11/29/2006	EP1470152A4 Peptides for increasing transfection efficiency
11/29/2006	EP1299724B1 Synthetic peptide for neurological disorders
11/29/2006	EP1218403B1 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
11/29/2006	EP1068331B1 Medicaments for inducing cytotoxic t-cells
11/29/2006	CN1871515A Artificial antibody comprising complementary peptide
11/29/2006	CN1871022A Peptides and compounds that bind to a receptor
11/29/2006	CN1869063A Preparation method of polypeptide for inhibiting gelatin enzyme A activity and its application
11/29/2006	CN1869062A Polypeptide for inhibiting gelatin enzyme A activity and its preparation method and application
11/29/2006	CN1869061A Peptidomimetic protease inhibitors
11/29/2006	CN1868458A Controlled release composition and method of producing the same
11/28/2006	US7141648 Synthesis of cyclosporin analogs
11/23/2006	WO2006125134A1 Peptides whose uptake by cells is controllable
11/23/2006	WO2006122652A2 Thiosuccinic acid derivatives and the use thereof
11/23/2006	WO2006106164B1 Dermopharmaceutical or cosmetic composition comprising enkephalin-derived peptides for reducing and/or eliminating facial wrinkles
11/23/2006	WO2006092230A3 Protein-binding camptothecin peptide derivatives and medicaments comprising the same
11/23/2006	WO2005086967A3 Therapeutic use of rm1 antigen
11/23/2006	US20060264608 Bi-directional synthesis of oligoguanidine transport agents
11/23/2006	US20060264605 Polypeptides having anti-HIV activity and compositions comprising same
11/23/2006	US20060264604 Anti-HBs monoclonal antibody
11/23/2006	US20060264378 Cxcr4 antagonist and use thereof
11/23/2006	US20060264358 Acylated nonadepsipeptides II
11/23/2006	US20060263848 Cysteine-containing peptides having antioxidant properties
11/23/2006	US20060263831 Interfacial biomaterials for binding ceramic substrates
11/23/2006	US20060263830 Interfacial biomaterials
11/23/2006	US20060263303 Compounds for Targeting Endothelial Cells, Compositions Containing the Same and Methods for Their Use
11/23/2006	US20060263294 Tumor targeting agents and uses thereof
11/23/2006	DE102005023761A1 An die Lck-SH3 und Hck-SH3 Domäne bindende Peptide At the Lck-SH3 and SH3 domain binding peptides Hck
11/23/2006	CA2611468A1 Peptides whose uptake by cells is controllable
11/22/2006	EP1724346A2 Peptides binding to the Lck-SH3 and to the Hck-SH3 domain
11/22/2006	EP1724280A1 Use of peptides as penetrating cell carriers
11/22/2006	EP1723167A1 Novel phosphorylated sequences of phosphatase cdc25b, antibodies directed against said sequences and use thereof
11/22/2006	EP1723166A2 Materials and methods relating to the treatment of glioblastomas
11/22/2006	EP1480998B1 Intermediates and methods for making heptapeptide oxytocin analogues
11/22/2006	EP1204865B1 Use of stabilised synthetic compounds in immunoassay
11/22/2006	EP1040120B1 Antifungal and antibacterial peptides
11/22/2006	CN1867579A Novel peptidomimetic NS3-serine protease inhibitors of hepatitis c virus
11/22/2006	CN1865282A Solid phase polypeptide synthesis preparation method for terlipressin
11/22/2006	CN1865281A Specific antibody GB11 T cell epitope peptide for resisting oophoroma and its uses
11/22/2006	CN1865280A Solid phase polypeptide synthesis preparation method for leuprorelin
11/22/2006	CN1865279A Solid phase polypeptide synthesis preparation method for thymopoietin pentapeptide
11/22/2006	CN1285607C Chinese hard tick neuropeptide and its preparing method and use
11/21/2006	US7138503 Synthetic molecules that specifically react with target sequences
11/21/2006	US7138488 Viricides
11/21/2006	US7138487 Contacting an aqueous solution of the lipopeptide antibiotic and a divalent metal ion with an organic solvent, thereby extracting the lipopeptide antibiotic into the organic solvent; andcontacting the organic solvent extract of the lipopeptide antibiotic with acid
11/21/2006	US7138486 Insulinotropic hormone derivatives and uses thereof
11/21/2006	US7138382 Compositions and methods for drug delivery using pH sensitive molecules
11/21/2006	US7138370 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents
11/21/2006	US7138369 Compounds and methods for modulating apoptosis
11/21/2006	US7138244 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule
11/21/2006	US7138127 Clostridial toxin derivatives and methods for treating pain
11/21/2006	US7138103 Completitive binding
11/21/2006	CA2341143C Production of motif-specific and context-independent antibodies using peptide libraries as antigens
11/16/2006	US20060258839 Cardiovascular disorders; antiinflammatory agents; resemble a G amphipathic helix of apolipoprotein J; phospholipids
11/16/2006	US20060258838 Preparation of somatostatin peptides

1 ... 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 ... 423